ENTITY
YiChang HEC ChangJiang Pharmaceutical

YiChang HEC ChangJiang Pharmaceutical (1558 HK)

137
Analysis
Health Care • China
YiChang HEC ChangJiang Pharmaceutical develops, manufactures, and sells pharmaceutical products, focusing on anti-viral, endocrine and metabolic, and cardiovascular diseases. Key products include Kewei (oseltamivir phosphate), Oumeining (telmisartan), and Ertongshu (benzbromarone). The company was founded in 2001 and is headquartered in Dongguan, China.
more
•14 Jul 2025 01:14

Merger Arb Mondays (14 Jul) - Shibaura, Topcon, Nissin, OneConnect, Insignia, PointsBet, ENN Energy

I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
792 Views
Share
bullish•Johns Lyng
•13 Jul 2025 06:15

(Mostly) Asia-Pac M&A: Johns Lyng, New World Resources, Oneconnect, Great Eastern, VIOL

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
461 Views
Share
•07 Jul 2025 06:15

Fengxiang (9977 HK): Composite Doc Out. 24th July H-Class Meeting

This is done. But this is an illiquid arb - and Hong Kong has seen two failed small-cap Schemes recently. Plus PAG is inviting dissent after...

Logo
387 Views
Share
•07 Jul 2025 01:21

Merger Arb Mondays (07 Jul) - Seven & I, Shibaura, Insignia, New World, ENN Energy, HKBN, Fengxiang

I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
1k Views
Share
bullish•Lens Technology
•06 Jul 2025 15:46

Weekly Deals Digest (06 Jul) - Lens Tech, FWD, Geekplus, NTT DC REIT, Fengxiang, HKBN, Insignia

A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...

Logo
608 Views
Share
x